Ghana

We are working with a number of institutes in Ghana to help them realise their dream of developing a drug discovery hub in their country. Over the next 10-15 years, they aim to establish a multi-centre programme which will be capable of undertaking hit discovery, hit to lead and lead optimisation across a range of diseases relevant to Ghana and the West African region.

Our role is to help them further develop their capabilities in screening, medicinal chemistry and drug metabolism and pharmacokinetics.

B&MGF Team visiting the Vice Chancellor at University of Ghana

Ghana Drug Discovery Hub Launch

NMIMR, University of Ghana and KNUST have been awarded US$1.8m by the Bill & Melinda Gates Foundation to improve existing drug discovery capacity in the region and establish a drug discovery hub. Initially focusing on malaria, the hub will expand in due course to serve a variety of diseases.

NMIMR Official Press Release

Our recent visit in June launched this new initiative and was attended by all the partners.

This award allows the institutes in Ghana to move closer to their overall aim of establish drug discovery capability in Ghana in the next 10-15 years. The plan is that there will be facilities in country that are capable of undertaking hit discovery, hit to lead and lead optimisation across a range of diseases relevant to both Ghana and the wider West African region.

Academy of Medical Sciences Network Meeting

Academy of Medical Sciences

We were jointly awarded an Academy of Medical Sciences for networking with NMIMR. Back in early 2020, we had planned to host a meeting in Ghana bringing all researchers who worked in Drug Discovery together to talk about their strengths, areas of focus, and needs to develop their research.

The planned meeting for January 2021 had to be put on hold due to travel restrictions at the time, and an online meeting was held in it’s place in December 2020.

From this online meeting, we developed a number of working groups with the researchers in Ghana – in chemistry, natural products and screening methods. These groups have given rise to training courses, further collaborations and short workshops.

In June 2022, we finally managed to get senior staff together again in Accra. This allowed us to catch up on research in drug discovery that has taken place and start planning our next round of activities.